Caesars Entertainment (CZR)’s Stock Insider Trade – Timothy Donovan Sells 5,354 Shares; IDEXX Laboratories, Inc. (IDXX) Had 7 Bullish Analysts

The EVP/ Gen Cnsl/Chief Legal RSO of Caesars Entertainment Corp, Timothy Donovan is in the stock market news today. It was stated in a legal report filled by Timothy Donovan and submitted to the U.S. SEC on 22-03-2018, he sold 5,354 shares from the public company having an approx. value of $66,825 U.S Dollars. The mentioned shares average price was $12.5. Now, Timothy Donovan holds a total of 453,141 shares or 0.07% of the company’s market cap (share price times the number of shares outstanding).

Among 11 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 7 have Buy rating, 2 Sell and 2 Hold. Therefore 64% are positive. IDEXX Laboratories had 27 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Neutral” rating by Bank of America on Thursday, September 29. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) earned “Buy” rating by Canaccord Genuity on Tuesday, June 13. The company was maintained on Monday, August 21 by Stifel Nicolaus. The company was maintained on Thursday, August 13 by Stifel Nicolaus. Credit Suisse maintained the shares of IDXX in report on Wednesday, April 13 with “Outperform” rating. Canaccord Genuity maintained the stock with “Buy” rating in Thursday, October 5 report. The rating was upgraded by Bank of America on Wednesday, August 23 to “Buy”. The company was maintained on Thursday, February 1 by Stifel Nicolaus. Stifel Nicolaus maintained it with “Buy” rating and $85 target in Monday, March 21 report. The firm has “Buy” rating given on Wednesday, July 20 by Canaccord Genuity. See IDEXX Laboratories, Inc. (NASDAQ:IDXX) latest ratings:

02/02/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $200 New Target: $220 Maintain
01/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $215.0 Maintain
01/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $211.0
29/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $210.0 Maintain
16/01/2018 Broker: PiperJaffray Rating: Overweight New Target: $200 Initiates Coverage On
23/10/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $185.0 Maintain
05/10/2017 Broker: Canaccord Genuity Rating: Buy New Target: $180.0 Maintain

Investors sentiment decreased to 0.81 in 2017 Q3. Its down 0.05, from 0.86 in 2017Q2. It dived, as 39 investors sold IDEXX Laboratories, Inc. shares while 196 reduced holdings. 55 funds opened positions while 146 raised stakes. 87.85 million shares or 15.07% more from 76.34 million shares in 2017Q2 were reported. Sun Life Finance has invested 0.01% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Great West Life Assurance Communications Can has invested 0.03% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Oregon Pub Employees Retirement Fund has 36,482 shares. Bnp Paribas Asset Mngmt Hldg Sa has invested 0.06% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Franklin Res Inc owns 0.03% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 403,028 shares. New York-based Alliancebernstein Limited Partnership has invested 0.02% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Patten Gp has 0.32% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 1,195 shares. State Of Wisconsin Board holds 0.05% or 115,281 shares. National Bank Of Nova Scotia reported 36,702 shares or 0.03% of all its holdings. 688,442 are owned by Federated Investors Incorporated Pa. Bbva Compass Bancorporation stated it has 0.03% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Qs Investors Ltd, New York-based fund reported 5,398 shares. 312,260 were accumulated by Axa. Lombard Odier Asset Mngmt (Switzerland) Sa owns 44,000 shares for 0.66% of their portfolio. Vanguard Grp Inc reported 0.07% in IDEXX Laboratories, Inc. (NASDAQ:IDXX).

Since January 9, 2018, it had 2 insider buys, and 6 selling transactions for $21.47 million activity. On Monday, February 5 MCKEON BRIAN P sold $1.20M worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 6,602 shares. AYERS JONATHAN W sold $8.96 million worth of stock or 54,000 shares. 2,974 shares were sold by JUNIUS DANIEL M, worth $565,232. END WILLIAM T also sold $737,939 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) on Thursday, February 22. Claflin Bruce L. had bought 1,000 shares worth $179,580. 1,000 shares were bought by Kingsley Lawrence D, worth $178,045 on Wednesday, February 14.

IDEXX Laboratories, Inc., together with its subsidiaries, develops, makes, and distributes services and products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company has market cap of $16.89 billion. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other divisions. It has a 65.95 P/E ratio. The firm provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.

The stock decreased 3.17% or $6.35 during the last trading session, reaching $193.88. About 536,969 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 83.30% since March 23, 2017 and is uptrending. It has outperformed by 66.60% the S&P500.

Among 6 analysts covering Caesars Entertainment (NASDAQ:CZR), 3 have Buy rating, 1 Sell and 2 Hold. Therefore 50% are positive. Caesars Entertainment has $16.0 highest and $9 lowest target. $13.67’s average target is 15.85% above currents $11.8 stock price. Caesars Entertainment had 10 analyst reports since December 14, 2015 according to SRatingsIntel. SunTrust maintained it with “Buy” rating and $16.0 target in Monday, February 5 report. The rating was initiated by Nomura with “Hold” on Friday, October 6. SunTrust maintained the stock with “Buy” rating in Tuesday, October 24 report. The stock of Caesars Entertainment Corporation (NASDAQ:CZR) has “Buy” rating given on Tuesday, June 6 by Oppenheimer. The stock of Caesars Entertainment Corporation (NASDAQ:CZR) has “Buy” rating given on Wednesday, May 31 by Oppenheimer. The stock of Caesars Entertainment Corporation (NASDAQ:CZR) earned “Buy” rating by Nomura on Wednesday, March 7. As per Monday, December 14, the company rating was maintained by Barclays Capital.

Caesars Entertainment Corporation, through its subsidiaries, provides casino-entertainment and hospitality services in the United States and internationally. The company has market cap of $8.08 billion. The firm operates through two divisions, Caesars Entertainment Resort Properties, and Caesars Growth Partners Casino Properties and Developments. It currently has negative earnings. It operates 15,000 slot machines and 1,200 table games, as well as other games comprising keno, poker, and race and sports books; and buffets, restaurants, bars, nightclubs, and lounges located throughout the company's casinos, as well as banquets and room service.